|
|
|
|
|
|
by shoyer
3570 days ago
|
|
|
> Later stage investment is increasingly focused on science
>
> Even five years ago it was incredibly hard to get funding for science-based ventures... This seems wrong to me. This may be true for consumer facing products or tech investors like YC, but it misses that biotech investors have been investing $1B+/quarter into science based startups for over a decade now [1]. I suspect that as far as absolute numbers go traditional biotech investing still dominates in this space. [1] http://www.forbes.com/sites/brucebooth/2015/07/23/the-ventur... |
|
|